Changes in mRNA expression precede changes in microRNA expression in lesional psoriatic skin during treatment with adalimumab

British Journal of Dermatology

Volumn 173, Issue 2, 2015, Pages 436-447

  Raaby, L ^a   Langkilde, A ^a   Kjellerup, R B ^a   Vinter, H ^a   Khatib, S H ^a   Hjuler, K F ^a   Johansen, C ^a   Iversen, L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; INTERLEUKIN 17; INTERLEUKIN 8; MESSENGER RNA; MICRORNA; MICRORNA 125A; MICRORNA 146A; MICRORNA 203; MICRORNA 214 3P; MICRORNA 23B; MICRORNA 31; MICRORNA LET 7D 5P; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AMINOQUINOLINE DERIVATIVE; ANTIINFLAMMATORY AGENT; IMIQUIMOD; IRRITANT AGENT;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DERMATITIS; FEMALE; HUMAN; IN SITU HYBRIDIZATION; LIMIT OF DETECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; PUNCH BIOPSY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY; THICKNESS; TREATMENT RESPONSE; ANIMAL; C57BL MOUSE; CASE CONTROL STUDY; DOWN REGULATION; DRUG EFFECTS; KNOCKOUT MOUSE; METABOLISM; MIDDLE AGED;

ADALIMUMAB; ADULT; AGED; AMINOQUINOLINES; ANIMALS; ANTI-INFLAMMATORY AGENTS; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; HUMANS; INTERLEUKIN-8; IRRITANTS; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; MIDDLE AGED; PSORIASIS; RNA, MESSENGER;

EID: 84941181691     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13721     Document Type: Article

References (44)

1. Standart N, Jackson RJ,. MicroRNAs repress translation of m7G-ppp-capped target mRNAs in vitro by inhibiting initiation and promoting deadenylation. Genes Dev 2007; 21: 1975-82.
2. Huntzinger E, Izaurralde E,. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 2011; 12: 99-110.
3. Bartel DP,. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
4. Ambros V,. The functions of animal microRNAs. Nature 2004; 431: 350-5.
5. Xie X, Lu J, Kulbokas EJ, et al,. Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature 2005; 434: 338-45.
6. Friedman RC, Farh KK, Burge CB, et al,. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19: 92-105.
7. Sonkoly E, Wei T, Janson PC, et al,. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One 2007; 2: e610.
8. Zibert JR, Lovendorf MB, Litman T, et al,. MicroRNAs and potential target interactions in psoriasis. J Dermatol Sci 2010; 58: 177-85.
9. Schneider MR,. MicroRNAs as novel players in skin development, homeostasis and disease. Br J Dermatol 2012; 166: 22-8.
10. Esteller M,. Non-coding RNAs in human disease. Nat Rev Genet 2011; 12: 861-74.
11. Xu N, Meisgen F, Butler LM, et al,. MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40. J Immunol 2013; 190: 678-88.
12. Hildebrand J, Rutze M, Walz N, et al,. A comprehensive analysis of microRNA expression during human keratinocyte differentiation in vitro and in vivo. J Invest Dermatol 2011; 131: 20-9.
13. Sonkoly E, Wei T, Pavez Lorie E, et al,. Protein kinase C-dependent upregulation of miR-203 induces the differentiation of human keratinocytes. J Invest Dermatol 2010; 130: 124-34.
14. Primo MN, Bak RO, Schibler B, et al,. Regulation of pro-inflammatory cytokines TNFalpha and IL24 by microRNA-203 in primary keratinocytes. Cytokine 2012; 60: 741-8.
15. Wei T, Xu N, Meisgen F, et al,. Interleukin-8 is regulated by miR-203 at the posttranscriptional level in primary human keratinocytes. Eur J Dermatol 2013; doi: 10.1684/ejd.2013.1997.
16. Meisgen F, Xu N, Wei T, et al,. MiR-21 is up-regulated in psoriasis and suppresses T cell apoptosis. Exp Dermatol 2012; 21: 312-14.
17. Kutty RK, Nagineni CN, Samuel W, et al,. Differential regulation of microRNA-146a and microRNA-146b-5p in human retinal pigment epithelial cells by interleukin-1beta, tumor necrosis factor-alpha, and interferon-gamma. Mol Vis 2013; 19: 737-50.
18. Taganov KD, Boldin MP, Chang KJ, et al,. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103: 12481-6.
19. Monticelli S, Ansel KM, Xiao C, et al,. MicroRNA profiling of the murine hematopoietic system. Genome Biol 2005; 6: R71.
20. Zhu S, Pan W, Song X, et al,. The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB 2, TAB 3 and IKK-alpha. Nat Med 2012; 18: 1077-86.
21. Nestle FO, Kaplan DH, Barker J,. Psoriasis. N Engl J Med 2009; 361: 496-509.
22. Langkilde A, Raaby L, Johansen C, et al,. MicroRNA normalization candidates for quantitative reverse-transcriptase polymerase chain reaction in real time in lesional and nonlesional psoriatic skin. Br J Dermatol 2013; 169: 677-81.
23. Mossner R, Reich K,. Management of severe psoriasis with TNF antagonists. Adalimumab, etanercept and infliximab. Curr Probl Dermatol 2009; 38: 107-36.
24. Soegaard-Madsen L, Johansen C, Iversen L, et al,. Adalimumab therapy rapidly inhibits p38 mitogen-activated protein kinase activity in lesional psoriatic skin preceding clinical improvement. Br J Dermatol 2010; 162: 1216-23.
25. Hendriks AG, van der Velden HM, Wolberink EA, et al,. The effect of adalimumab on key drivers in the pathogenesis of psoriasis. Br J Dermatol 2014; 170: 571-80.
26. Johansen C, Vinter H, Soegaard-Madsen L, et al,. Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFalpha therapy. Br J Dermatol 2010; 163: 1194-204.
27. Pivarcsi A, Meisgen F, Xu N, et al,. Changes in the level of serum microRNAs in psoriasis patients after anti-tumor necrosis factor-alpha therapy. Br J Dermatol 2013; 169: 563-70.
28. Pasparakis M, Alexopoulou L, Episkopou V, et al,. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 1996; 184: 1397-411.
29. van der Fits L, Mourits S, Voerman JS, et al,. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 2009; 182: 5836-45.
30. Tusher VG, Tibshirani R, Chu G,. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116-21.
31. Hol J, Wilhelmsen L, Haraldsen G,. The murine IL-8 homologues KC, MIP-2, and LIX are found in endothelial cytoplasmic granules but not in Weibel-Palade bodies. J Leukoc Biol 2010; 87: 501-8.
32. Zaba LC, Suarez-Farinas M, Fuentes-Duculan J, et al,. Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes. J Allergy Clin Immunol 2009; 124: 1022-10.e1-395.
33. Ceppi M, Pereira PM, Dunand-Sauthier I, et al,. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci USA 2009; 106: 2735-40.
34. Gantier MP, McCoy CE, Rusinova I, et al,. Analysis of microRNA turnover in mammalian cells following Dicer1 ablation. Nucleic Acids Res 2011; 39: 5692-703.
35. Sato F, Tsuchiya S, Terasawa K, et al,. Intra-platform repeatability and inter-platform comparability of microRNA microarray technology. PLoS One 2009; 4: e5540.
36. Mestdagh P, Hartmann N, Baeriswyl L, et al,. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Methods 2014; 11: 809-15.
37. Kraemer A, Chen IP, Henning S, et al,. UVA and UVB irradiation differentially regulate microRNA expression in human primary keratinocytes. PLoS One 2013; 8: e83392.
38. Donadelli M, Dando I, Fiorini C, et al,. Regulation of miR-23b expression and its dual role on ROS production and tumour development. Cancer Lett 2014; 349: 107-13.
39. Vennegaard MT, Bonefeld CM, Hagedorn PH, et al,. Allergic contact dermatitis induces upregulation of identical microRNAs in humans and mice. Contact Dermatitis 2012; 67: 298-305.
40. Boyman O, Hefti HP, Conrad C, et al,. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J Exp Med 2004; 199: 731-6.
41. Zenz R, Eferl R, Kenner L, et al,. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 2005; 437: 369-75.
42. Guinea-Viniegra J, Jimenez M, Schonthaler HB, et al,. Targeting miR-21 to treat psoriasis. Sci Transl Med 2014; 6: 225re1.
43. Ralfkiaer U, Hagedorn PH, Bangsgaard N, et al,. Diagnostic micr-oRNA profiling in cutaneous T-cell lymphoma (CTCL). Blood 2011; 118: 5891-900.
44. Yi R, Poy MN, Stoffel M, et al,. A skin microRNA promotes differentiation by repressing 'stemness'. Nature 2008; 452: 225-9.